Hyophen Tablets and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Hyophen Tablets and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate
Brand name: Hyophen, Prosed/DS, Urophen MB
Synonyms: Hyophen
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyophen Tablets-Insulin degludec Subcutaneous
- Hyophen Tablets-Insulin detemir
- Hyophen Tablets-Insulin Detemir (Cartridges and Prefilled Syringes)
- Hyophen Tablets-Insulin Detemir (Vials)
- Hyophen Tablets-Insulin detemir Subcutaneous
- Hyophen Tablets-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Hyoscine Injection
- Insulin degludec and liraglutide Subcutaneous-Hyoscyamine
- Insulin degludec and liraglutide Subcutaneous-Hyoscyamine and phenyltoloxamine
- Insulin degludec and liraglutide Subcutaneous-Hyoscyamine Extended-Release Tablets
- Insulin degludec and liraglutide Subcutaneous-Hyoscyamine Injection
- Insulin degludec and liraglutide Subcutaneous-Hyoscyamine Liquid